✓
Open
21 Jan 2026
✓
Close
23 Jan 2026
3
Allotment
—
✓
Listing
Thu, Jan 29, 2026
Price Band
₹128 to ₹135
Issue Size
57,40,000 shares (agg. up to ₹77 Cr)
Lot Size
1,000 Shares
Listing Date
Thu, Jan 29, 2026
✦ AI Insight
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 52.19x |
Restated Financials (₹ Cr.)
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 78.12 | 66.79 | 43.91 | 39.48 |
| Total Income | 48.65 | 76.95 | 67.57 | 89.38 |
| Profit After Tax | 8.14 | 12.10 | 3.41 | 7.60 |
| EBITDA | 12.83 | 19.11 | 7.34 | 11.03 |
| NET Worth | 36.13 | 23.88 | 11.78 | 8.37 |
| Reserves and Surplus | 20.61 | 23.73 | 11.63 | 8.22 |
| Total Borrowing | 25.07 | 31.20 | 23.18 | 19.87 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Curis Lifesciences Ltd. | SME | ₹27.52 Cr | ₹128 | 12.44 | ₹141.00 | +10.16% | ₹198.80 |
| Aptus Pharma Ltd. | SME | ₹13.02 Cr | ₹70 | 11.29 | ₹84.84 | +21.20% | ₹333.35 |
| Asston Pharmaceuticals Ltd. | SME | ₹27.56 Cr | ₹123 | 17.83 | ₹124.95 | +1.59% | ₹110.00 |
| Influx Healthtech Ltd. | SME | ₹58.57 Cr | ₹96 | 13.04 | ₹126.20 | +31.46% | ₹283.70 |
| Astonea Labs Ltd. | SME | ₹37.67 Cr | ₹135 | 27.36 | ₹135.65 | +0.48% | ₹289.00 |
| Accretion Pharmaceuticals Ltd. | SME | ₹29.75 Cr | ₹101 | 21.29 | ₹82.95 | -17.87% | ₹210.00 |
| Amwill Health Care Ltd. | SME | ₹59.98 Cr | ₹111 | 13.81 | ₹93.25 | -15.99% | ₹43.51 |
| Corona Remedies Ltd. | Mainboard | ₹655.37 Cr | ₹1062 | 43.47 | ₹1,438.40 | +35.44% | ₹2,093.20 |
| Rubicon Research Ltd. | Mainboard | ₹1,377.50 Cr | ₹485 | 55.75 | ₹628.20 | +29.53% | ₹1,860.60 |
| Amanta Healthcare Ltd. | Mainboard | ₹126.00 Cr | ₹126 | 34.59 | ₹141.75 | +12.50% | ₹201.86 |
| Anlon Healthcare Ltd. | Mainboard | ₹121.03 Cr | ₹91 | 17.67 | ₹91.73 | +0.80% | ₹15.61 |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Capital Expenditure for Construction and Development of Telemedicine Operational Facilities | 13.67 |
| 2 | Purchase of CRM Software and Hardware Infrastructure | 1.42 |
| 3 | Human Resources | 5.44 |
| 4 | Repayment/Prepayment of loan | 12.50 |
| 5 | Working Capital Requirement | 22.90 |
| 6 | General Corporate Purposes | 10.00 |
| 7 | Issue Expenses | 11.57 |
| Total | 77.49 |
About KRM Ayurveda IPO
Updated on Aug 5, 2026
Contact Details
KRM Ayurveda Ltd. AddressA-16, G T Karnal RoadIndustrial AreaDelhi, New Delhi, 110033+91- 9289101700compliance@krmayurveda.comVisit Website